June 30th, 2010 - 09:46 GMT WIN Symposium: Registration Still Open for Unique Personalized Cancer Medicine Event Registration for the second annual WIN Symposium on personalized cancer medicine Read more
April 6th, 2010 - 11:04 GMT WIN Symposium on personalized cancer care receives endorsement from ASCO, ESMO and OECI
April 6th, 2010 - 09:30 GMT Merck Serono: Erbitux granted extended use in Japan for 1st-line treatment of mCRC Patients with KRAS wild-type tumors
